Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single-cell CRISPR screening of autism risk genes in brain organoids

ABSTRACT: Single-cell CRISPR screening of autism risk genes in brain organoids

PROVIDER: PRJEB64174 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	ERR11670039_1.fastq.gz	Fastqsanger.gz
	ERR11670039_2.fastq.gz	Fastqsanger.gz
	ERR11669943_1.fastq.gz	Fastqsanger.gz
	ERR11669943_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

CRISPR screening of autism risk genes in brain organoids

Project description:CRISPR screening of autism risk genes in brain organoids

| PRJEB63996 | ENA

CRISPR screening of autism risk genes in brain organoids

Project description:Organoids were generated from cells infected with pooled lentivirus library. The lentiviral libraries deliver dual-gRNAs targeting 36 high-risk ASD genes in parallel. With or without 4-OHT induction of eCas9 expression, organoids were dissociated at specific developmental stages. Single cells were sorted and bulk genomic DNA was extracted. Target amplification was performed using genomic DNA to analyze gRNA and unique clone barcode representation.

2023-07-09 | E-MTAB-13140 | biostudies-arrayexpress

Single-cell CRISPR screening of autism risk genes in brain organoids

Project description:Single-cell RNA sequencing of 4-month-old telencephalon organoids. Organoids were generated from cells infected with pooled lentivirus library. The lentiviral library delivers dual-gRNAs targeting 36 high-risk ASD genes in parallel. Organoids were dissociated after 4 months of in vitro differentiation and maturation. Single cells were sorted and subjected to 10X genomics 3' kits.

2023-07-09 | E-MTAB-13148 | biostudies-arrayexpress

Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening [sgRNA]

Project description:Murine trophoblast organoids contain trophoblast cell types. We used CRISPR SCREENING to analyze the trophoblast organoids derived from TS (mTOs).

2023-10-25 | GSE245217 | GEO

In vivo Perturb-Seq reveals neuronal and glial abnormalities associated with autism risk genes

Project description:We developed and applied a scalable genetic screening approach, in vivo Perturb-Seq, to functionally evaluate 35 autism spectrum disorder/neurodevelopmental delay (ASD/ND) de novo loss-of-function risk genes (see https://www.biorxiv.org/content/10.1101/791525v1 for complete list). Using CRISPR-Cas9, we introduced frameshift mutations in these risk genes in pools, within the developing mouse brain in utero, followed by single-cell RNA sequencing of perturbed cells in the postnatal brain. We identified cell type-specific and evolutionarily conserved gene modules from both neuronal and glial cell classes. Recurrent gene modules and cell types are affected across this cohort of perturbations, representing key cellular effects across sets of ASD/ND risk genes.

2020-12-01 | GSE157977 | GEO

Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening

Project description:Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening

| PRJNA1027430 | ENA

CRISPR Screening in Glioblastoma

Project description:This is an in vitro genome-wide CRISPR/cas9 screen in human glioblastoma stem cells, screening for genes essential for survival of these cells. These cells express cas9 and have been transfected with a guide RNA library causing gene knockouts. We will analyse the sequencing data for depletion of guide RNAs. In this particular study, we will do RNA sequencing to correlate CRISPR with expression levels in specific cancer cell subpopulations. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/

2016-03-22 | E-ERAD-448 | biostudies-arrayexpress

Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening [sgRNA]

Project description:Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening [sgRNA]

| PRJNA1027380 | ENA

Cerebral organoids model neocortical development disrupted by 16p11.2 CNV in autism

Project description:The 16p11.2 is the most common copy number variant (CNV) associated with Autism Spectrum Disorder (ASD). We used patient-derived cerebral organoids to investigate neurodevelopmental pathways dysregulated by dosage changes of 16p11.2 CNV. To investigate molecular dysregulation in DEL and DUP organoids, we carried out RNA sequencing and Tandem Mass Tag mass spectrometry (TMT-MS) on 1-month and 3-month organoids from the same samples. In proteomic analyses, we quantified a total of 6126 proteins in 1-month and 5481 proteins in 3-month organoids, with 13 and 11 proteins from within 16p11.2 CNV, respectively. Transcriptomic and proteomic profiling of organoids identifies the key drivers of functional effect by 16p11.2 CNV during neocortical development.

2019-12-19 | MSV000084727 | MassIVE

Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening [scRNA-seq]

Project description:Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening [scRNA-seq]

| PRJNA934269 | ENA